bentracimab monoclonal antibody medication shown phase one two clinical trials function reversal agent clotting drug ticagrelor acts inhibitor sold brand name brilinta among investigation use major lifethreatening bleeding patients treated commercially available monoclonal article stub help wikipedia expanding drug article relating blood blood forming organs stub help wikipedia expanding ithttpsenwikipediaorgwikibentracimab